|Articles|August 1, 2016
- Pharmaceutical Executive-08-01-2016
- Volume 36
- Issue 8
Pharmaceutical Executive, August 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Pharm Exec's 15th Annual Industry Auditalmost 10 years ago
The Industry Audit: Fifteen Years Rightalmost 10 years ago
Dealmaking in 2016: It’s Complicatedalmost 10 years ago
Steady Hands: AmerisourceBergen's Peyton Howellalmost 10 years ago
Drug Shortages Raise Economic and Ethical Challengesalmost 10 years ago
The ‘Cure’-All for 21st Century Data Sharingabout 10 years ago
European Pharma and the Unified Patent Courtabout 10 years ago
An EU Referendum ... on Drug Pricing?about 10 years ago
Country Report: HungaryAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5